Cart 193 Product Products 57 755,54 € (empty)
Product successfully added to your shopping cart
Quantity
Total
There are 193 items in your cart. There is 1 item in your cart.
Total products (tax excl.) 57 755,54 €
Total shipping (tax excl.) 265,00 €
Total (tax excl.) 58 020,54 €
Data sheet of LYN monoclonal antibody, clone 2H8D7
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Mouse |
| Applications | WB,ELISA |
More info about LYN monoclonal antibody, clone 2H8D7
| Brand: | Abnova |
| Reference: | MAB5531 |
| Product name: | LYN monoclonal antibody, clone 2H8D7 |
| Product description: | Mouse monoclonal antibody raised against partial recombinant LYN. |
| Clone: | 2H8D7 |
| Isotype: | IgG2b |
| Gene id: | 4067 |
| Gene name: | LYN |
| Gene alias: | FLJ26625|JTK8 |
| Gene description: | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
| Immunogen: | Recombinant protein corresponding to human LYN. |
| Form: | Liquid |
| Recommend dilutions: | ELISA (1:10000) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In PBS, pH 7.2 (50% glycerol, 0.01% sodium azide) |
| Storage instruction: | Store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Mouse |
| Antigen species / target species: | Human |
| Reactivity: | Human |
| Application image: |  |
| Application image note: | Western blot analysis using LYN monoclonal antibody, clone 2H8D7 (Cat # MAB5531) against truncated LYN recombinant protein (Lane 1), HL-60 cell lysate (Lane 2). |
| Applications: | WB,ELISA |
| Shipping condition: | Dry Ice |
| Publications: | Mapping of a gene determining tuberous sclerosis to human chromosome 11q14-11q23.Smith M, Smalley S, Cantor R, Pandolfo M, Gomez MI, Baumann R, Flodman P, Yoshiyama K, Nakamura Y, Julier C, et al.. Genomics. 1990 Jan;6(1):105-14. |